Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 114

    US government seeks part of Oklahoma $270 million opioid settlement

    US government seeks part of Oklahoma $270 million opioid settlement

    Medical Dialogues Bureau30 Jun 2019 9:00 AM IST
    It's not clear how much of the state's settlement the federal government is seeking or where the money would come from. Oklahoma's settlement in March...
    Former USFDA boss Scott Gottlieb to join Pfizer board

    Former USFDA boss Scott Gottlieb to join Pfizer board

    Farhat Nasim29 Jun 2019 4:15 PM IST
    Dr Scott Gottlieb is also an elected member of the National Academy of Medicine.New Delhi: Drugmaker Pfizer has recently announced the election of Dr...
    USFDA Warning: Medtronic recalls insulin pumps over cybersecurity vulnerabilities

    USFDA Warning: Medtronic recalls insulin pumps over cybersecurity vulnerabilities

    Medical Dialogues Bureau29 Jun 2019 1:49 PM IST
    The recalled pumps are Medtronic's MiniMed 508 insulin pump and MiniMed Paradigm series insulin pumps. Medtronic is unable to adequately update the...
    Stop use of trademark deceptively similar to Glaxo antibiotic Augmentin: Delhi High Court to AFDIL

    Stop use of trademark deceptively similar to Glaxo antibiotic Augmentin: Delhi High Court to AFDIL

    Farhat Nasim29 Jun 2019 11:56 AM IST
    The court's order came on a plea by Glaxo Group Ltd which sought to restrain AFDIL from advertising, marketing or in any manner doing business under...
    Alembic Pharma clears USFDA inspection at oncology unit in Panelav

    Alembic Pharma clears USFDA inspection at oncology unit in Panelav

    Farhat Nasim29 Jun 2019 10:02 AM IST
    This was a first scheduled inspection and Alembic Pharma passed the inspection without any Form 483 Observation.New Delhi: Alembic Pharmaceuticals...
    Regeneron Pharma gets USFDA nod for Dupixent to treat rhinosinusitis with nasal polyps

    Regeneron Pharma gets USFDA nod for Dupixent to treat rhinosinusitis with nasal polyps

    Farhat Nasim29 Jun 2019 10:00 AM IST
    The efficacy and safety of Dupixent were established in two studies with 724 patients, 18 years and older with chronic rhinosinusitis with nasal...
    Court hears appeal on Pharma Bro Martin Shkreli fraud case

    Court hears appeal on Pharma Bro Martin Shkreli fraud case

    Medical Dialogues Bureau29 Jun 2019 9:00 AM IST
    NEW YORK: A federal appeals court heard arguments Friday over whether the securities fraud conviction against former drug company CEO Martin Shkreli,...
    Glenmark Pharma receives USFDA approval for generic version of Vytorin tablets

    Glenmark Pharma receives USFDA approval for generic version of Vytorin tablets

    Medical Dialogues Bureau28 Jun 2019 12:39 PM IST
    The approved product, Ezetimibe and Simvastatin tablets, is a generic version of MSD International's Vytorin tablets.New Delhi: Glenmark...
    Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab

    Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab

    Medical Dialogues Bureau28 Jun 2019 12:30 PM IST
    The initial tenure of the agreement between Sun Pharma and CMS shall be 15 years from the first commercial sale of Tildrakizumab in Greater China and...
    Lupin gets tentative USFDA nod for generic version of Mirabegron ER tablets

    Lupin gets tentative USFDA nod for generic version of Mirabegron ER tablets

    Farhat Nasim28 Jun 2019 11:10 AM IST
    The approval by the US Food and Drug Administration (USFDA) is for a generic version of Mirabegron ER tablets of strengths 25 mg and 50 mg, Lupin said...
    Bayer contested Glyphosate use will eventually end, says German Chancellor

    Bayer contested Glyphosate use will eventually end, says German Chancellor

    Medical Dialogues Bureau28 Jun 2019 9:15 AM IST
    Bayer, which has been struggling to outrun the glyphosate crisis, two weeks ago announced it would spend 5 billion euros in researching alternative...
    Future of cheaper versions of biologic medicines in doubt

    Future of cheaper versions of biologic medicines in doubt

    Medical Dialogues Bureau28 Jun 2019 9:00 AM IST
    Biologic medicines treat cancer, rare diseases and autoimmune disorders like rheumatoid arthritis and colitis. Biosimilars are near-copies of them....
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Top Pharmacy Courses That Rule the Industry

    Top Pharmacy Courses That Rule the Industry

    MEDICREA UNiD IB3D Patient-Matched interbody cages get USFDA clearance

    MEDICREA UNiD IB3D Patient-Matched interbody cages get USFDA clearance

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    China offers tariff exemptions on US medical equipment amid virus outbreak

    China offers tariff exemptions on US medical equipment amid virus outbreak

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok